[Clinical studies on the short term use of "Kavosan"].
The inflammation and plaque-inhibiting effect of KAVOSAN was tested in 43 probands with gingivitis in two test series. Irrespective of the type of oral care, a statistically significant improvement in the degree of inflammation and a reduction of plaque were observed after application of the active agent when compared to a placebo preparation, both in cases where plaque was removed as well as cases where plaque was not removed.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001881:Borates / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003773:Dental Plaque / Q000517:prevention & control*; D004341:Drug Evaluation; D006801:Humans; D012964:Sodium / Q000494:pharmacology*; D013644:Tartrates / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D001881:Borates; D013644:Tartrates; D012964:Sodium
Klinische Untersuchung über die kurzfristige Anwendung von "Kavosan"